Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Axsome Therapeutics (AXSM) Debt Ratio: 2022-2025

Historic Debt Ratio for Axsome Therapeutics (AXSM) over the last 4 years, with Sep 2025 value amounting to 0.28.

  • Axsome Therapeutics' Debt Ratio fell 16.33% to 0.28 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.28, marking a year-over-year decrease of 16.33%. This contributed to the annual value of 0.33 for FY2024, which is 6.01% up from last year.
  • According to the latest figures from Q3 2025, Axsome Therapeutics' Debt Ratio is 0.28, which was down 4.35% from 0.29 recorded in Q2 2025.
  • Axsome Therapeutics' 5-year Debt Ratio high stood at 0.56 for Q1 2022, and its period low was 0.28 during Q3 2025.
  • For the 3-year period, Axsome Therapeutics' Debt Ratio averaged around 0.32, with its median value being 0.32 (2025).
  • As far as peak fluctuations go, Axsome Therapeutics' Debt Ratio slumped by 45.61% in 2023, and later climbed by 13.52% in 2024.
  • Over the past 4 years, Axsome Therapeutics' Debt Ratio (Quarterly) stood at 0.30 in 2022, then climbed by 3.79% to 0.31 in 2023, then rose by 6.01% to 0.33 in 2024, then declined by 16.33% to 0.28 in 2025.
  • Its last three reported values are 0.28 in Q3 2025, 0.29 for Q2 2025, and 0.32 during Q1 2025.